|
Volumn 62, Issue 2, 2002, Pages 445-449
|
Copper-64-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for the prevention of tumor growth at wound sites following laparoscopic surgery: Monitoring therapy response with microPET and magnetic resonance imaging
a a b b b c d |
Author keywords
[No Author keywords available]
|
Indexed keywords
COPPER 64;
COPPER 64 PYRUVALDEHYDE BIS(N4 METHYLTHIOSEMICARBAZONE);
UNCLASSIFIED DRUG;
ABDOMINAL WALL;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CANCER CELL;
CANCER INHIBITION;
COLON RESECTION;
CONTROLLED STUDY;
DRUG DISTRIBUTION;
LAPAROSCOPIC SURGERY;
MAXIMUM TOLERATED DOSE;
METASTASIS;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PERITONEUM METASTASIS;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
SYRIAN HAMSTER;
TROCAR;
TUMOR GROWTH;
TUMOR VOLUME;
WOUND;
ABDOMINAL MUSCLES;
ABDOMINAL NEOPLASMS;
ANIMALS;
CELL DIVISION;
COLONIC NEOPLASMS;
COPPER RADIOISOTOPES;
CRICETINAE;
LAPAROSCOPY;
MAGNETIC RESONANCE IMAGING;
MESOCRICETUS;
NEOPLASM SEEDING;
ORGANOMETALLIC COMPOUNDS;
RADIOPHARMACEUTICALS;
THIOSEMICARBAZONES;
TISSUE DISTRIBUTION;
TOMOGRAPHY, EMISSION-COMPUTED;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
EID: 0037081175
PISSN: 00085472
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (43)
|
References (30)
|